Particle Size Analysis in Pharmaceutics: Principles, Methods and Applications
暂无分享,去创建一个
[1] T. Allen. Particle Size Measurement , 1965, Nature.
[2] Recent Developments and Prospects , 1978 .
[3] Paul A. Baron,et al. Calibration and Use of the Aerodynamic Particle Sizer (APS 3300) , 1986 .
[4] John E. Brockmann,et al. APS Response to Nonspherical Particles and Experimental Determination of Dynamic Shape Factor , 1990 .
[5] W. D. Griffiths,et al. The behaviour of regular-shaped non-spherical particles in a TSI aerodynamic particle sizer , 1991 .
[6] A. Rolland. Particulate carriers in dermal and transdermal drug delivery: myth or reality? , 1993 .
[7] Y. Cheng,et al. Calibration and performance of an API Aerosizer , 1993 .
[8] Gary H. Ganser,et al. A rational approach to drag prediction of spherical and nonspherical particles , 1993 .
[9] C. Laguerie,et al. Response of Laser Diffraction Particle Sizer to Anisometric Particles , 1994 .
[10] H. Yuasa,et al. Studies on the Granulation Process of Granules for Tableting with a High Speed Mixer. II. Influence of Particle Size of Active Substance on Granulation , 1995 .
[11] H. Chan,et al. Physicochemical characterization of a new respirable form of nedocromil. , 1995, Journal of pharmaceutical sciences.
[12] R. Niven,et al. The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation , 1996 .
[13] T. Nagai,et al. Optimization of Size Distribution of Granules for Tablet Compression , 1996 .
[14] K. Englmeier,et al. Aerodynamics and aerosol particle deaggregation phenomena in model oral-pharyngeal cavities , 1996 .
[15] Effect of drug particle size on the release behaviour of NaCl-matrix systems , 1996 .
[16] Dissolution rate studies of pharmaceutical multisized powders — A practical approach using the coulter method , 1996 .
[17] N Lotan,et al. Large porous particles for pulmonary drug delivery. , 1997, Science.
[18] B. H. Kaye,et al. The Effect of Shape on Intermethod Correlation of Techniques for Characterizing the Size Distribution of Powder. Part 1: Correlating the Size Distribution Measured by Sieving, Image Analysis, and Diffractometer Methods , 1997 .
[19] Terence Allen,et al. Powder sampling and particle size measurement , 1997 .
[20] Shulin Ding. RECENT DEVELOPMENTS IN OPHTHALMIC DRUG DELIVERY , 1998 .
[21] R. Langer,et al. Recent advances in pulmonary drug delivery using large, porous inhaled particles. , 1998, Journal of applied physiology.
[22] M. Yoshida,et al. Tableting of Coated Particles. II. Influence of Particle Size of Pharmaceutical Additives on Protection of Coating Membrane from Mechanical Damage during Compression Process. , 1998 .
[23] R. Haskell. Characterization of submicron systems via optical methods. , 1998, Journal of pharmaceutical sciences.
[24] J. Juraszek,et al. Structural and magnetic transformations of annealed Tb/Fe multilayers , 1998 .
[25] S. Rozouvan,et al. Raman correlation spectroscopy: A method for studying chemical composition and dynamics of disperse systems , 1998 .
[26] Structural phenomena in hydrogel-drug systems , 1999 .
[27] N. K. Sinha,et al. Drag on non-spherical particles: an evaluation of available methods , 1999 .
[28] F. Podczeck. The Influence of Particle Size Distribution and Surface Roughness of Carrier Particles on the in vitro Properties of Dry Powder Inhalations , 1999 .
[29] G. Rowley,et al. Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles. , 1999, Drug development and industrial pharmacy.
[30] B. H. Kaye,et al. The Effect of Shape on Intermethod Correlation of Techniques for Characterizing the Size Distribution of Powder. Part 2: Correlating the Size Distribution as Measured by Diffractometer Methods, TSI-Amherst Aerosol Spectrometer, and Coulter Counter , 1999 .
[31] N. Chigier,et al. OPTICAL MEASUREMENT OF NEBULIZER SPRAYS: A QUANTITATIVE COMPARISON OF DIFFRACTION, PHASE DOPPLER INTERFEROMETRY, AND TIME OF FLIGHT TECHNIQUES , 2000 .
[32] D. Culler,et al. Comparison of methods , 2000 .
[33] J. Dressman,et al. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[34] R. Neuman,et al. Direct adhesion measurements of pharmaceutical particles to gelatin capsule surfaces , 2000 .
[35] N A Peppas,et al. Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles. , 2000, International journal of pharmaceutics.
[36] M. J. Clarke,et al. The formulation of powder inhalation systems containing a high mass of nedocromil sodium trihydrate. , 2001, Journal of pharmaceutical sciences.
[37] V. Préat,et al. Comparison of particle sizing techniques in the case of inhalation dry powders. , 2001, Journal of pharmaceutical sciences.
[38] D. Grant,et al. Influence of crystal shape on the tableting performance of L-lysine monohydrochloride dihydrate. , 2001, Journal of pharmaceutical sciences.
[39] Vidya Swaminathan,et al. Polydisperse Powder Mixtures: Effect of Particle Size and Shape on Mixture Stability , 2002, Drug development and industrial pharmacy.
[40] T. Vandamme,et al. Pulmonary drug delivery systems: recent developments and prospects. , 2002, Critical reviews in therapeutic drug carrier systems.
[41] Parisa A. Bahri,et al. Estimating Average Particle Size by Focused Beam Reflectance Measurement (FBRM) , 2002 .
[42] C. Strumiłło,et al. DRYING KINETICS AND PARTICLE RESIDENCE TIME IN SPRAY DRYING , 2002 .
[43] Richard J Martin. Therapeutic significance of distal airway inflammation in asthma. , 2002, The Journal of allergy and clinical immunology.
[44] John D Sherwood,et al. A review of the terms agglomerate and aggregate with a recommendation for nomenclature used in powder and particle characterization. , 2002, Journal of pharmaceutical sciences.
[45] B. Shekunov,et al. Physical Properties of Supercritically-Processed and Micronised Powders for Respiratory Drug Delivery , 2002 .
[46] M. Aulton. Pharmaceutics : the science of dosage form design , 2002 .
[47] L. Nagao,et al. Recommendations to the Food and Drug Administration: Metered Dose Inhaler Tests and Methods in the Chemistry, Manufacturing, and Controls Draft Guidances for Metered Dose Inhalers and Dry Powder Inhalers , 2002 .
[49] D. F. Steele,et al. Characterization of a surface modified dry powder inhalation carrier prepared by “particle smoothing” , 2002, The Journal of pharmacy and pharmacology.
[50] M. L. González-Rodríguez,et al. In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[51] B. Shekunov,et al. Aerosolisation behaviour of micronised and supercritically-processed powders , 2003 .
[52] Michael G Somekh,et al. Amplitude and phase microscopy for sizing of spherical particles. , 2003, Applied optics.
[53] J. Varshosaz,et al. Nasal delivery of insulin using chitosan microspheres , 2004, Journal of microencapsulation.
[54] Stephen P. Newman,et al. Improved Lung Delivery from a Passive Dry Powder Inhaler Using an Engineered PulmoSphere® Powder , 2002, Pharmaceutical Research.
[55] Jeffry D. Schroeter,et al. Fundamental Effects of Particle Morphology on Lung Delivery: Predictions of Stokes' Law and the Particular Relevance to Dry Powder Inhaler Formulation and Development , 2002, Pharmaceutical Research.
[56] S. Horkovics-Kovats. Characterization of an Active Pharmaceutical Ingredient by Its Dissolution Properties: Amoxicillin Trihydrate as a Model Drug , 2004, Chemotherapy.
[57] A. Zimmer,et al. Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopy. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[58] Si-Shen Feng,et al. Nanoparticles of biodegradable polymers for new-concept chemotherapy , 2004, Expert review of medical devices.
[59] Production of Powders for Respiratory Drug Delivery , 2004 .
[60] I. Chang,et al. Transdermal delivery of mixnoxidil with block copolymer nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[61] B. Shekunov,et al. Supercritical fluid technology for drug product development , 2004 .
[62] Lawrence X. Yu,et al. Applications of process analytical technology to crystallization processes. , 2004, Advanced drug delivery reviews.
[63] P. Stewart,et al. Particle Interactions Involved in Aerosol Dispersion of Ternary Interactive Mixtures , 2002, Pharmaceutical Research.
[64] U. Kompella,et al. Pulmonary Delivery of Deslorelin: Large-Porous PLGA Particles and HPβCD Complexes , 2004, Pharmaceutical Research.
[65] P. Lucas,et al. Protein Deposition from Dry Powder Inhalers: Fine Particle Multiplets as Performance Modifiers , 1998, Pharmaceutical Research.
[66] R H Guy,et al. Skin penetration and distribution of polymeric nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[67] F. Goli,et al. Tableting of Eudragit RS and Propranolol Hydrochloride Solid Dispersion: Effect of Particle Size, Compaction Force, and Plasticizer Addition on Drug Release , 2004, Drug development and industrial pharmacy.
[68] Antonio M. Rabasco,et al. Relationship Between Drug Percolation Threshold and Particle Size in Matrix Tablets , 1996, Pharmaceutical Research.
[69] David E. Bugay,et al. Physical Characterization of Pharmaceutical Solids , 1995, Pharmaceutical Research.
[70] K. Johnston,et al. Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs , 2004, Drug development and industrial pharmacy.
[71] A. Vila,et al. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[72] B. Shekunov,et al. Thermal Analysis of Trace Levels of Polymorphic Impurity in Salmeterol Xinafoate Samples , 2003, Pharmaceutical Research.
[73] Barrett E. Rabinow,et al. Nanosuspensions in drug delivery , 2004, Nature Reviews Drug Discovery.
[74] I. Larson,et al. Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures. , 2004, Journal of pharmaceutical sciences.
[75] R. W. Wood,et al. Nebulization of NanoCrystals™: Production of a Respirable Solid-in-Liquid-in-Air Colloidal Dispersion , 2004, Pharmaceutical Research.
[76] Michael Hindle,et al. Aerodynamic sizing of metered dose inhalers: an evaluation of the Andersen and Next Generation pharmaceutical impactors and their USP methods. , 2004, Journal of pharmaceutical sciences.
[77] Jerzy Bałdyga,et al. Fluid Dynamics, Mass Transfer, and Particle Formation in Supercritical Fluids , 2004 .
[78] A. Bernkop‐Schnürch,et al. Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[79] Theerayuth Kaewamatawong,et al. Acute Pulmonary Toxicity Caused by Exposure to Colloidal Silica: Particle Size Dependent Pathological Changes in Mice , 2005, Toxicologic pathology.
[80] A. C. Hunter,et al. Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[81] Nanoparticle technology for drug delivery: from nanoparticles to cutting-edge delivery strategies - part I. , 2005, IDrugs : the investigational drugs journal.
[82] Daryl L Roberts,et al. Relationship of stage mensuration data to the performance of new and used cascade impactors. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[83] Barrett Rabinow. Pharmacokinetics of drugs administered in nanosuspension. , 2005, Discovery medicine.
[84] M. Goldenberg,et al. Micrometer-Scale Particle Sizing by Laser Diffraction: Critical Impact of the Imaginary Component of Refractive Index , 2005, Pharmaceutical Research.
[85] O. Usmani,et al. Regional Lung Deposition and Bronchodilator Response as a Function of β2-Agonist Particle Size , 2005 .
[86] Joachim List,et al. Direct Imaging of Very Fast Particles Opens the Application of the Powerful (Dry) Dispersion for Size and Shape Characterization , 2005 .
[87] Julie W. Fitzpatrick,et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.
[88] Pratibhash Chattopadhyay,et al. Nanoparticles of Poorly Water-Soluble Drugs Prepared by Supercritical Fluid Extraction of Emulsions , 2006, Pharmaceutical Research.
[89] B. Shekunov. Nanoparticle technology for drug delivery: from nanoparticles to cutting-edge delivery strategies - part II. , 2005, IDrugs : the investigational drugs journal.
[90] N. Chew,et al. Effect of amino acids on the dispersion of disodium cromoglycate powders. , 2005, Journal of pharmaceutical sciences.
[91] Isidoro Caraballo,et al. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery. , 2006, International journal of pharmaceutics.
[92] W. Kreyling,et al. Ultrafine particle-lung interactions: does size matter? , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[93] Lai Wah Chan,et al. Evaluation of sodium alginate as drug release modifier in matrix tablets. , 2006, International journal of pharmaceutics.
[94] T. Xia,et al. Toxic Potential of Materials at the Nanolevel , 2006, Science.
[95] Jolyon P. Mitchell,et al. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: Comparison of andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer , 2003, AAPS PharmSciTech.
[96] Shrenik P. Shah,et al. Liposomal amikacin dry powder inhaler: Effect of fines on in vitro performance , 2004, AAPS PharmSciTech.
[97] Vincent J. Sullivan,et al. Formulation of a dry powder influenza vaccine for nasal delivery , 2006, AAPS PharmSciTech.
[98] K Ann McKibbon,et al. Current status and future prospects. , 2008, Health information and libraries journal.
[99] A. Hussain,et al. Assuring quality and performance of sustained and controlled release parenterals: Workshop report , 2008, AAPS PharmSci.
[100] J. Zimmerman. Exposure-response relationships and drug interactions of sirolimus , 2004, The AAPS Journal.
[101] Anthony J. Hickey,et al. Particle size analysis: AAPS workshop report, cosponsored by the Food and Drug Administration and the United States Pharmacopeia , 2004, The AAPS Journal.